Complex genetics of Tourette's Syndrome: Piecing the puzzle

A. Wagle Shukla,S. Fox

DOI: https://doi.org/10.1002/mds.27218

IF: 9.698

2017-01-21

Movement Disorders

Abstract:Tourette’s syndrome (TS) is a complex neuropsychiatric disorder with a strong genetic component. There is a 60-fold higher risk of developing TS in children born to affected parents in comparison to the general population. Despite a strong heritability, there is scarce data on the susceptible genes and the underlying mutations. Although linkage analyses have found several candidate regions, there is little consensus seen across studies. Aggregated data from single-nucleotide polymorphism studies found TS as highly polygenic, with the majority of inherited risk distributed throughout the genome. To date, genome-wide significant loci could not be identified with certainty. Thus, disentangling the complex genetic architecture of TS has remained a major challenge. The discovery of copy number variations (CNVs) in structural genome analysis has led to increased understanding of the genetics of neuropsychiatric disorders. CNVs are small and large alterations to genomes, such as a gain or loss of coding sequence, which may overlap over several genes essential for biological pathways. Multiple rare CNVs (implying an underlying disease process) have been implicated in mental retardation, autism, and schizophrenia. These neuropsychiatric disorders are observed to share common biological pathways given that the genes contained in the rare CNVs share a common purpose of normal synaptic structure and neurotransmission. In this new large study of 6,527 unrelated individuals of European ancestry (2,434 TS cases and 4,093 ancestry-matched controls) published by Huang and colleagues, recurrent, rare CNVs were identified in two loci, in the NRXN1 (deletions) and CNTN6 (duplications), each conferring a significant substantial increase in the TS risk. They found that increased global CNV burden was mainly driven by large, rare, clinically relevant events. The current study findings are robust and promising given that previously exonic CNVs in the NRXN1 (presynaptic celladhesion molecule involved in synaptogenesis and synaptic transmission) did not survive genome-wide correction for multiple testing. The finding of duplications in the CNTN6 (encoding a cell-adhesion molecule involved in synaptogenesis and orientation of dendrites of pyramidal neurons) is also a novel association for TS. The current study was well characterized for obsessive compulsive disorder and attention deficit disorder, which are common comorbidities in TS. However, the full scope of phenotype associated with these rare CNVs is not clear and needs further characterization in future studies. Nevertheless, the study establishes a global enrichment in the burden of large, rare CNVs, a finding that will likely have significant impact on the future of TS genetics.